Provention Bio, Inc.·4

Nov 23, 9:34 PM ET

Yi Miyoko Christina 4

4 · Provention Bio, Inc. · Filed Nov 23, 2022

Insider Transaction Report

Form 4
Period: 2022-11-22
Yi Miyoko Christina
Chief Operations Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-11-22+45,000195,000 total
    Exercise: $5.88From: 2022-11-22Exp: 2031-12-16Common Stock, par value $0.0001 (45,000 underlying)
Footnotes (3)
  • [F1]As previously reported on a Form 4 filed on December 20, 2021, on December 16, 2021 the Reporting Person was granted a stock option for 300,000 shares of Common Stock, 150,000 of which option shares vest in four equal annual installments commencing on December 16, 2022 and 150,000 of which option shares vest upon completion of certain performance milestones. This amount represents the vesting of 45,000 of the 150,000 performance option shares on November 22, 2022 upon the satisfaction of certain performance milestones.
  • [F2]The stock options were granted pursuant to the Issuer's 2020 Inducement Plan.
  • [F3]Represents the 150,000 time-based option shares referred to in footnote (1) plus the 45,000 vested performance option shares referred to in footnote (1).

Documents

1 file
  • 4
    ownership.xmlPrimary